This content is for educational purposes only and is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Read more.
Marsden360
Marsden360
What is Marsden360 circulating tumour DNA (ctDNA) testing?
Transcript
Over the last few years, the growth in genomic testing has been
absolutely exponential. So, it is now incredibly difficult for me to think
of a cancer where genomic testing does not play a role in the accurate
and faster diagnosis, prognostic information, or the selection of
treatment for patients.
The Marsden360 is our tech transfer ctDNA test from Guardant. So, this harnesses all of the research and development that Guardant have put into their circulating tumour DNA and allows us to offer this for all of our patients in the UK and beyond.
So, for those who aren't familiar with the test, it's a blood test which looks for tiny fragments of the tumour DNA in the blood and allows us to look for molecular markers that allow us to firstly get a diagnosis or prognostic information for that patient, and also to potentially find molecularly matched treatments to ensure that patients are getting the best possible treatment.
The Marsden360 is our tech transfer ctDNA test from Guardant. So, this harnesses all of the research and development that Guardant have put into their circulating tumour DNA and allows us to offer this for all of our patients in the UK and beyond.
So, for those who aren't familiar with the test, it's a blood test which looks for tiny fragments of the tumour DNA in the blood and allows us to look for molecular markers that allow us to firstly get a diagnosis or prognostic information for that patient, and also to potentially find molecularly matched treatments to ensure that patients are getting the best possible treatment.